PHARMACOKINETICS AND PHARMACODYNAMICS AS WELL AS METABOLISM FOLLOWING ORALLY AND INTRAVENOUSLY ADMINISTERED C-14 GLIPIZIDE, A NEW ANTIDIABETIC

被引：45

作者：

SCHMIDT, HAE

SCHOOG, M

SCHWEER, KH

WINKLER, E

机构：

[1] NUCL RES CTR,INST RADIOCHEM,KARLSRUHE,WEST GERMANY

[2] PFIZER GMBH,DEPT CLIN PHARMACOL,KARLSRUHE,WEST GERMANY

[3] PROTESTANT HOSP BETHESDA,DEPT NUCL MED,DUISBURG,WEST GERMANY

来源：

关键词：

D O I：

10.1007/BF01218442

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：320 / 330

页数：11

共 17 条

[1]

AMBROGI V, 1971, ARZNEI-FORSCHUNG, V21, P200

[2]

AMBROGI V, 1972, ARZNEI-FORSCHUNG, V22, P542

[3]

AMBROGI V, 1971, ARZNEI-FORSCHUNG, V21, P204

[4]

AMBROGI V, 1971, ARZNEI-FORSCHUNG, V21, P208

[5]

DONOFRIO F, 1972, ARZNEIMITTEL-FORSCH, V22, P1879

[6]

EMANUELI A, 1972, ARZNEIMITTEL-FORSCH, V22, P1881

[7]

FEDELE D, 1972, ARZNEIMITTEL-FORSCH, V22, P1885

[8]

GOLDANIG.GC, 1973, ARZNEIMITTEL-FORSCH, V23, P242

[9]

GRECO VA, 1971, MINERVA MED, V62, P2829

[10]

HAJDU P, 1969, JAN TEG C ROTT, P32